Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead

Taylor and Francis Group, Critical Reviews in Biotechnology, p. 1-16

Journal article published in 2015 by Everardo González-González, Mario Moisés Alvarez

This paper is available in a repository.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by